Cancer Economics: on Variations in the Costs of Treating Cancer

Etzioni R.D. , Feuer E.J. , Sullivan S.D. . On the use of survival analysis techniques to estimate medical care costs. J Health Econ. 1999; 18: 365–380.

Zhou X.H. , Melfi C.A. , Hui S.L. . Methods for comparison of cost data. Ann Intern Med. 1997; 127(8, pt 2): 752–756.

Fuchs V.R. . Has cost containment gone too far? Milbank Q. 1986; 64: 479–488.

Virgo K.S. , Vernava A.M. , Longo W.E. . Cost of patient follow-up after potentially curative colorectal cancer treatment. JAMA. 1995; 273: 1837–1841.

Hodgson D.C. , Fuchs C.S. , Ayanian J.Z. . Impact of patient and provider characteristics on the treatment and outcomes of colorectal cancer. J Natl Cancer Inst. 2001; 93: 501–515.

Variations in charges for two major breast cancer surgeries, U.S., 1996. Oncology (Huntingt). 1998; 12: 889, 893-896, 901-902.

Khan Z.M. , Rascati K.L. , Koeller J.M. . Economic analysis of carboplatin versus cisplatin in lung and ovarian cancer. Pharmacoeconomics. 1999; 16: 43–57.

Bloomston M. , D'Angelo P. , Galliano D. . One hundred consecutive advanced breast biopsy instrumentation procedures: complications, costs, and outcomes. Ann Surg Oncol. 1999; 6: 195–199.

Riley G.F. , Potosky A.L. , Lubitz J.D. . Medicare payments from diagnosis to death for elderly cancer patients by stage at diagnosis. Med Care. 1995; 33: 828–841.

Taplin S.H. , Barlow W. , Urban N. . Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care. J Natl Cancer Inst. 1995; 87: 417–426.

Legorreta A.P. , Brooks R.J. , Leibowitz A.N. . Cost of breast cancer treatment. Arch Intern Med. 1996; 156: 2197–2201.

Polednak A.P. , Shevchenko I.P. , Flannery J.T. . Estimating breast cancer treatment charges in Connecticut. Conn Med. 1996; 60: 263–267.

Etzioni R. , Urban N. , Baker M. . Estimating the costs attributable to a disease with application to ovarian cancer. J Clin Epidemiol. 1996; 49: 95–103.

Fireman B.H. , Quesenberry C.P. , Somkin C.P. . Cost of care for cancer in a health maintenance organization. Health Care Financ Rev. 1997; 18: 51–76.

Brown M.L. , Riley G.F. , Potosky A.L. . Obtaining long-term disease specific costs of care: application to Medicare enrollees diagnosed with colorectal cancer. Med Care. 1999; 37: 1249–1259.

Penson D.F. , Schonfeld W.H. , Flanders S.C. . Relationship of first-year costs of treating localized prostate cancer to initial choice of therapy and stage at diagnosis: results from the CAPSURE database. Urology. 2001: 57; 499–503.

Hillner B.E. , McDonald M.K. , Desch C.E. . Costs of care associated with non-small-cell lung cancer in a commercially insured cohort. J Clin Oncol. 1998; 16: 1420–1424.

Penberthy L. , Retchin S.M. , McDonald M.K. . Predictors of Medicare costs in elderly beneficiaries with breast, colorectal, lung, or prostate cancer. Health Care Manag Sci. 1999; 2: 149–160.

Du W. , Touchette D. , Vaitkevicius V.K. . Cost analysis of pancreatic carcinoma treatment. Cancer. 2000; 89: 1917–1924.

Chirikos T.N. , Ruckdeschel J.C. , Krischer J.P. . Impact of clinical trials on the costs of cancer care. Med Care. 2001; 39: 373–383.

Polednak A.P. , Shevchenko I.P. . Hospital charges for terminal care of cancer patients dying before age 65. J Health Care Finance. 1998; 25: 26–34.

Husbands J.M. , Weber R.S. , Karpati R.L. . Clinical care pathways: decreasing resource utilization in head and neck surgical patients. Otolaryngol Head Neck Surg. 1999; 121: 755–759.

Barlow W.E. , Taplin S.H. , Yoshida C.K. . Cost comparison of mastectomy versus breast-conserving therapy for early-stage breast cancer. J Natl Cancer Inst. 2001; 93: 447–455.

Potosky A.L. , Riley G.F. , Lubitz J.D. . Potential for cancer related health services research using a linked Medicare-tumor registry database. Med Care. 1993; 31: 732–748.

Desch C.E. , Penberthy L.T. . Using state and federal claims data to evaluate the patterns and costs of cancer care. Cancer Treat Res. 1998; 97: 53–69.

Brown M.L. , Lipscomb J. , Snyder C. . The burden of illness of cancer: economic cost and quality of life. Annu Rev Public Health. 2001; 22: 91–113.

Sherman E.J. , Pfister D.G. , Ruchlin H.S. . The collection of indirect and non-medical direct costs (COIN) form: a new tool for collecting the invisible costs of androgen independent prostate carcinoma. Cancer. 2001; 91: 841–853.

Perkel S.J. . Financial modeling for global pricing: the NCCN breast cancer prototype. National Comprehensive Cancer Network. Oncology (Huntingt). 1999; 13: 73–74.

Chirikos T.N. . Identifying efficiently and economically operated hospitals: the prospects and pitfalls of applying frontier regression techniques. J Health Polit Policy Law. 1998; 23: 879–904.